Press Release
Company News
Employee News

Avantis Investors® Builds Up Distribution Team in Germany and Austria

07/10/2025
FRANKFURT
Pay Fahlbusch

With the increasing demand of UCITS ETFs in Europe, Avantis Investors®, a $75 billion* investment offering from the $283 billion** global asset manager American Century Investments®, today announces that Pay Fahlbusch has joined the business as head of wholesale and ETFs for Germany and Austria. Fahlbusch will report to Head of EMEA Richard Adams in the UK. This is the third recent addition in the region focused on fostering strong relationships with wealth managers, following the additions of Rebecca Bilek-Chee and Robbie Main.

"The response from European investors has been positive," said Adams. "Pay has worked directly with clients for several years and his expertise is going to help us reach more people."

Fahlbusch joins the firm from AXA Investment Managers, where he spent almost the last two years as head of ETF sales Germany & Austria responsible for developing the newly created ETF-franchise in those two markets for the French Asset Manager. Before that, Fahlbusch spent several years at UBS Asset Management and DWS (Xtrackers) working as member of their ETF teams, covering clients in Germany.

Huge Growth Potential in Europe for UCITS ETFs

"We are seeing huge growth potential in Europe, and we are delighted to have Pay join our team and help us bring our low-cost, broadly diversified strategies to clients," said Phil McInnis, chief investment strategist for Avantis.

About American Century Investments

  • Who We Are

    American Century Investments is a leading global asset manager focused on delivering investment results and building long-term client relationships while supporting breakthrough medical research.

  • Quick Facts

    Founded in 1958, American Century Investments' 1,400 employees serve financial professionals, institutions, corporations and individual investors from offices in Kansas City, Missouri; New York; Los Angeles; Santa Clara, California; Portland, Oregon; London; Frankfurt, Germany; Hong Kong; and Sydney.

  • Management

    Jonathan S. Thomas is chairman, chief executive officer and president, and Victor Zhang serves as chief investment officer.

  • Giving Back

    Delivering investment results to clients enables American Century Investments to distribute over 40% of its dividends to the Stowers Institute for Medical Research, a 500-person, nonprofit basic biomedical research organization. The Institute owns more than 40% of American Century Investments and has received dividend payments of more than $2 billion since 2000.

Day time view of American Century Headquarters in Kansas City, Missouri
*

Assets under supervision as of 7/3/25.

**

Assets under supervision as of 7/3/25.

©2025 American Century Proprietary Holdings, Inc. All rights reserved.

Contact Avantis Investors

Close Contact Us Icon

833-928-2684

inquiries@avantisinvestors.com

This website is intended for Institutional and Professional Investors, not Retail Investors.


You should consider the fund's investment objectives, risks, and charges and expenses carefully before you invest. The fund's prospectus or summary prospectus, which can be obtained by visiting Avantisinvestors.com or by calling 833-928-2684, contains this and other information about the fund, and should be read carefully before investing. Investments are subject to market risk.

American Century Investments is not responsible for and does not endorse any comments, content, advertising, products, advice, opinions, recommendations or other materials on or available directly or via hyperlinks from Facebook, Twitter or any third-party website. Facebook, Twitter and LinkedIn are registered trademarks of their respective owners.

Mutual Funds: American Century Investment Services, Inc., Distributor.

Exchange Traded Funds (ETFs): Foreside Fund Services, LLC – Distributor, not affiliated with American Century Investment Services, Inc.

© 2025 American Century Proprietary Holdings, Inc. All rights reserved.

Cookie Settings